AstraZeneca Shares and Voting Rights Update
Company Announcements

AstraZeneca Shares and Voting Rights Update

AstraZeneca (GB:AZN) has released an update.

AstraZeneca PLC has announced that as of August 31, 2024, the company’s total issued share capital with voting rights comprises 1,550,286,637 ordinary shares, with none held in treasury. This figure is crucial for shareholders to calculate their notification requirements for changes in shareholdings under the UK’s Financial Conduct Authority rules. AstraZeneca is a leading biopharmaceutical company that markets its prescription medicines globally across various therapeutic areas.

For further insights into GB:AZN stock, check out TipRanks’ Stock Analysis page.

Related Articles
TheFlyAIM reports preliminary data in Phase 1b/2 study of Ampligen, Imfinzi
TheFlyAstraZeneca’s Fasenra approved in U.S. to treat adults with EGPA
TipRanks UK Auto-Generated NewsdeskAstraZeneca’s Fasenra Wins FDA Approval for Rare Vasculitis
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App